Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New stent study aims to ease jaundice in cancer patients

NCT ID NCT06750146

Symptom relief Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused This study
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 10, 2026 · Updated 5 times

Summary

This study looks at whether a special stent (Hot AXIOS) can improve quality of life for people with bile duct blockages caused by cancer, when standard drainage fails. About 162 adults will receive the stent during an endoscopic procedure. The main goal is to see if jaundice symptoms get better two months after the procedure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 162 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patients 18 years or older 2. Willing and able to comply with study procedures and provide written informed consent 3. Patients with failed ERCP for treatment of suspected malignant biliary obstruction 4. Patients for whom an indication for Hot AXIOS™ stent placement has been determined Exclusion Criteria: 1. Women who are pregnant, nursing or planning to become pregnant during the study 2. Patients with immediately resectable tumor or resectable during the two months of the study 3. Patients for whom the placement of a double pigtail prosthesis is planned by the investigator during the index procedure 4. Current participation in another investigation drug or device study that could interfere with the endpoints of this study 5. Persons under guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Malignant biliary stenosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bile duct cancer biliary tract cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Malignant biliary stenosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    18 sites. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHRU Hopital Pontchaillou

    Rennes, 35033, France

  • CHRU de Nancy

    Vandœuvre-lès-Nancy, 54500, France

  • CHU Limoges

    Limoges, 87042, France

  • CHU Nice

    Nice, 06202, France

  • CHU Rangueil

    Toulouse, 31059, France

  • CHU Reims

    Reims, 51092, France

  • CHU de Besançon

    Besançon, 25030, France

  • CHU de Poitiers

    Poitiers, 86021, France

  • CHU de Strasbourg

    Strasbourg, 67091, France

  • Centre Hospitalier de Vichy

    Vichy, 03200, France

  • Clinique Jules Verne

    Nantes, 44300, France

  • Clinique Saint-Hilaire

    Rouen, 76000, France

  • Clinique des Cedres, Ramsay Sante

    Cornebarrieu, 31700, France

  • Hopital Europeen Georges-Pompidou

    Paris, 75908, France

  • Hopital Paris Saint-Joseph

    Paris, 75014, France

  • Hopital Prive Jean Mermoz

    Lyon, 69008, France

  • Hopital Saint Antoine

    Paris, 75012, France

  • Santé Atlantique

    Saint-Herblain, 44800, France